M&T Bank’s Eli Lilly LLY Stock Holding History

M&T Bank’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$221M	Sell	240,540 -10,152	-4%	-$10.3M	0.76%	26
2025 Q4	$269M	Buy	250,692 +6,540	+3%	+$6.25M	0.87%	25
2025 Q3	$186M	Sell	244,152 -9,813	-4%	-$7.3M	0.63%	34
2025 Q2	$198M	Buy	253,965 +7,311	+3%	+$5.68M	0.68%	29
2025 Q1	$204M	Sell	246,654 -14,170	-5%	-$11.8M	0.74%	28
2024 Q4	$201M	Sell	260,824 -5,998	-2%	-$4.97M	0.67%	31
2024 Q3	$236M	Buy	266,822 +1,867	+0.7%	+$1.68M	0.78%	26
2024 Q2	$240M	Buy	264,955 +35,448	+15%	+$28.4M	0.82%	26
2024 Q1	$179M	Buy	229,507 +23,669	+11%	+$16.8M	0.62%	32
2023 Q4	$120M	Sell	205,838 -11,185	-5%	-$6.53M	0.44%	50
2023 Q3	$117M	Sell	217,023 -6,835	-3%	-$3.52M	0.47%	44
2023 Q2	$105M	Sell	223,858 -2,776	-1%	-$1.16M	0.39%	60
2023 Q1	$77.8M	Sell	226,634 -8,770	-4%	-$2.96M	0.3%	82
2022 Q4	$86.1M	Buy	235,404 +1,807	+0.8%	+$641K	0.35%	75
2022 Q3	$75.5M	Buy	233,597 +2,895	+1%	+$917K	0.34%	72
2022 Q2	$64.2M	Buy	230,702 +35,845	+18%	+$10.8M	0.3%	82
2022 Q1	$55.8M	Sell	194,857 -6,198	-3%	-$1.6M	0.25%	99
2021 Q4	$55.5M	Sell	201,055 -4,567	-2%	-$1.16M	0.23%	102
2021 Q3	$47.5M	Sell	205,622 -3,269	-2%	-$807K	0.21%	108
2021 Q2	$47.9M	Buy	208,891 +2,296	+1%	+$461K	0.21%	110
2021 Q1	$38.6M	Sell	206,595 -11,217	-5%	-$2.19M	0.17%	127
2020 Q4	$36.8M	Sell	217,812 -9,126	-4%	-$1.36M	0.16%	125
2020 Q3	$33.6M	Sell	226,938 -1,936	-0.8%	-$300K	0.16%	119
2020 Q2	$37.6M	Sell	228,874 -6,222	-3%	-$955K	0.2%	108
2020 Q1	$32.6M	Sell	235,096 -8,375	-3%	-$1.15M	0.19%	113
2019 Q4	$32M	Sell	243,471 -2,549	-1%	-$295K	0.15%	97
2019 Q3	$27.5M	Sell	246,020 -4,007	-2%	-$446K	0.14%	142
2019 Q2	$27.7M	Sell	250,027 -5,924	-2%	-$698K	0.14%	141
2019 Q1	$33.2M	Sell	255,951 -1,559	-0.6%	-$190K	0.17%	122
2018 Q4	$29.8M	Sell	257,510 -8,771	-3%	-$980K	0.17%	123
2018 Q3	$28.6M	Sell	266,281 -232	-0.1%	-$23.2K	0.14%	139
2018 Q2	$22.7M	Sell	266,513 -20,317	-7%	-$1.67M	0.12%	164
2018 Q1	$22.2M	Sell	286,830 -13,221	-4%	-$1.06M	0.12%	162
2017 Q4	$25.3M	Sell	300,051 -5,758	-2%	-$490K	0.13%	152
2017 Q3	$26.2M	Sell	305,809 -4,649	-1%	-$381K	0.14%	142
2017 Q2	$25.6M	Sell	310,458 -1,793	-0.6%	-$146K	0.15%	142
2017 Q1	$26.3M	Sell	312,251 -18,111	-5%	-$1.45M	0.16%	135
2016 Q4	$24.3M	Buy	330,362 +8,714	+3%	+$649K	0.15%	145
2016 Q3	$25.8M	Sell	321,648 -5,052	-2%	-$404K	0.16%	134
2016 Q2	$25.7M	Sell	326,700 -358	-0.1%	-$27K	0.17%	134
2016 Q1	$23.6M	Sell	327,058 -186,508	-36%	-$14.1M	0.16%	139
2015 Q4	$43.3M	Sell	513,566 -7,089	-1%	-$588K	0.29%	85
2015 Q3	$43.6M	Sell	520,655 -224,584	-30%	-$19M	0.3%	82
2015 Q2	$62.2M	Buy	745,239 +4,387	+0.6%	+$334K	0.38%	60
2015 Q1	$53.8M	Buy	740,852 +4,473	+0.6%	+$318K	0.34%	71
2014 Q4	$50.8M	Buy	736,379 +6,452	+0.9%	+$436K	0.32%	70
2014 Q3	$47.3M	Buy	729,927 +554,105	+315%	+$35.1M	0.3%	65
2014 Q2	$10.9M	Sell	175,822 -6,422	-4%	-$383K	0.46%	49
2014 Q1	$10.7M	Sell	182,244 -3,172	-2%	-$177K	0.45%	50
2013 Q4	$9.46M	Buy	185,416 +27,036	+17%	+$1.35M	0.4%	57
2013 Q3	$7.97M	Sell	158,380 -4,898	-3%	-$256K	0.38%	59
2013 Q2	$8.02M	Buy	+163,278	New	+$8.88M	0.39%	55

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

M&T Bank's LLY Position: Q1 2026 in Review

M&T Bank reduced its Eli Lilly (LLY) stake by 4% in Q1 2026, selling an estimated $10.3M and leaving 240,540 shares worth $221M. The position accounts for 0.76% of the portfolio, ranked #26.

M&T Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $269M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

M&T Bank held 240,540 shares of Eli Lilly worth $221M as of Q1 2026.
M&T Bank sold 10,152 Eli Lilly shares in Q1 2026, an estimated $10.3M.
Eli Lilly made up 0.76% of M&T Bank's portfolio in Q1 2026, its #26 holding.
M&T Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
M&T Bank's Eli Lilly position peaked at $269M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.